1.
Saygin C, Cannova J, Stock W, Muffly L. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica 2022;107(12):2783-2793; https://doi.org/10.3324/haematol.2022.280638.